If you have any ground beef in your refrigerator or freezer, there are three serious alerts you need to know about.
The first is an expanding E. coli outbreak.
Here’s an overview from Food Safety News:
Ground beef, consumed at home or in restaurants, and possibly purchased in large packages from grocery stores just might be the source of the now six-state E. coli O103 outbreak, according to CDC.
In an update of its last report just three days earlier, the Centers for Disease Control and Prevention (CDC) in Atlanta shared its preliminary epidemiologic information that implicates ground beef for infecting at least 109 people. (source)
So far, seventeen people have been hospitalized, reports the CDC. No cases of hemolytic uremic syndrome (a type of kidney failure) have been reported, and no deaths have been reported.
Officials still don’t know the exact source of the tainted meat.
Traceback investigations are being conducted to determine the source of ground beef supplied to grocery stores and restaurant locations where infected people ate. Currently, no common supplier, distributor, or brand of ground beef has been identified.
As of April 12, cases have been reported in Indiana, Georgia, Ohio, Kentucky, Tennessee, and Virginia.
CDC is not recommending that consumers avoid eating ground beef at this time. Consumers and restaurants should handle ground beef safely and cook it thoroughly to avoid foodborne illness.
At this time, CDC is not recommending that retailers stop serving or selling ground beef. (source)
For guidelines on how to safely handle and cook raw beef, please see the CDC’s instructions here: Outbreak of E. coli Infections.
Symptoms of E. coli O103 include severe stomach cramps, diarrhea (often bloody), and vomiting, and usually lasts 5-7 days. Some people who are infected also develop a fever. People usually get sick from Shiga toxin-producing E. coli (STEC) 3–4 days after drinking or eating something that contains the bacteria, but illness can start anywhere from 1 to 10 days after infection. Some people with a STEC infection may get a type of kidney failure called hemolytic uremic syndrome.
The CDC referred to the outbreak as a “rapidly evolving investigation”. We will update this article with new information as it is made available.
In an unrelated outbreak that was announced at the end of March, Aurora Packing Company, Inc. recalled approximately 4,838 pounds of beef heel and chuck tender products that may be contaminated with E. coli O157:H7.
Two companies have recalled beef products for possible plastic contamination.
Earlier this month, AdvancePierre Foods recalled more than 20,000 pounds of frozen beef patties for possible plastic contamination:
AdvancePierre Foods is voluntarily recalling 20,373 pounds of Tenderbroil Patties CN Fully Cooked Flamebroiled Beef Patties. The recall is limited to food service customers, and affected products are not available for purchase in retail stores. No other AdvancePierre Foods products are affected.
Two consumers reported they found pieces of soft purple plastic in the product. Even though these reports involved only two items, out of an abundance of caution, the company is recalling 1,449 cases of product. AdvancePierre Foods has received no reports of injuries or illnesses associated with the affected product.
The product was produced at one plant location on November 30, 2018. Each 14.06-pound case contains three bags with 30 pieces each, and bears the establishment code 2260E, a date code of EN83340303 and case code 155-525-0.
This product was sent to distribution centers in the following states: Arizona, Florida, Illinois, Indiana, Michigan, Minnesota, Missouri, North Dakota, Nebraska, New York, Ohio, Pennsylvania, Texas and Wisconsin. (source)
The recall includes approximately 43,292 pounds of ground beef that were produced on March 2, 2019. The affected beef has an establishment number of EST. 562M inside the USDA mark of inspection or printed on the bottom of the package label. The contaminated ground beef was shipped to retail locations throughout Michigan and Wisconsin. (source)
The recalled beef includes:
- 1-pound plastic wrapped ground beef loaves labeled as fresh from Meijer GROUND BEEF 80% LEAN 20% FAT. It has a case code of 47283 and a sell by date of 4/10/2019 located on the label.
- 1-pound plastic wrapped ground beef loaves labeled as fresh from Meijer GROUND BEEF 85% LEAN 15% FAT. It has a case code of 47285 and a sell by date of 4/10/2019 located on the label.
- 1-pound plastic wrapped ground beef loaves labeled as fresh from Meijer GROUND BEEF 90% LEAN 10% FAT. It has a case code of 47290 and a sell by date of 4/10/2019 located on the label.
- 1-pound plastic wrapped ground beef loaves labeled as LEAN GROUND BEEF. It has a case code of 42093 and a sell by date of 4/10/2019 located on the label.
- 1-pound plastic wrapped ground beef loaves labeled as CERTIFIED GROUND SIRLOIN. It has a case code of 42090 and a sell by date of 4/10/2019 located on the label.
- 1-pound plastic wrapped ground beef loaves labeled as CERTIFED GROUND ROUND. It has a case code of 42085 and a sell by date of 4/10/2019 located on the label.
- 1-pound plastic wrapped ground beef loaves labeled as Fresh! BLACK ANGUS GROUND CHUCK. It has a case code of 42283 and a sell by date of 4/10/2019 located on the label.
- 1-pound plastic wrapped ground beef loaves labeled as CERTIFIED GROUND CHUCK. It has a case code of 81631 and a sell by date of 4/10/2019 located on the label.
- 1-pound plastic wrapped ground beef loaves labeled as GROUND BEEF. It has a case code of 81629 and a sell by date of 4/10/2019 located on the label.
Consumers are urged to check their freezers for the recalled ground beef. It should be thrown away or returned to the place of purchase. It should not be consumed.
One company has issued a recall for meat that was not inspected.
Last Friday, Denver Processing LLC recalled approximately 13,865 pounds of raw pork and beef products that were produced without the benefit of federal inspection and outside inspection hours, reports Food Safety News:
The recalled products bear the establishment number “EST. 6250” within the USDA mark of inspection on the case label and directly outside of the USDA mark of inspection on the product label. These items were shipped to retail locations in Colorado, Kansas, New Mexico, Utah, and Wyoming. (source)
For a full list of products Denver Processing is recalling, please click here: Denver Processing recalls port and beef that went without inspection
What do you think?
Will you be checking your freezer for these products? Please share your thoughts in the comments.
About the Author
Dagny Taggart is the pseudonym of an experienced journalist who needs to maintain anonymity to keep her job in the public eye. Dagny is non-partisan and aims to expose the half-truths, misrepresentations, and blatant lies of the MSM.
This article was sourced from The Organic Prepper.
FDA inspections reveal that factories in China and India produce CARCINOGEN-TAINTED blood pressure and heart medications
A shocking investigation has just revealed serious contamination issues for blood pressure medications made in foreign factories. Drugs made at plants located in China and India are tainted with carcinogenic substances, according to a report from the FDA. Estimates suggest that one out of every three American adults takes a blood pressure medication. How many people will be affected by this recall is currently unknown.
Medications from at least 30 different companies were found to contain excessive amounts of carcinogenic material. The federal agency was forced to put out dozens of recalls for an array of blood pressure medications and other drugs in the last several months due to product contamination.
Of course, the agency isn’t that concerned. While they may have issued a recall on the tainted drugs, the FDA is still encouraging patients who’ve received contaminated medication to continue taking their prescription until their pharmacist gives them an untainted dose, or until they get a different prescription from their doctor.
Tainted drugs take over
As Daily Mail reports, the FDA has identified dozens of generic drugs containing valsartan, irbesartan and losartan that are actually contaminated with carcinogenic compounds. Other angiotensin II receptor blockers and ARB medicines may be contaminated as well.
UPI reports that the federal agency has found traces of up to three carcinogenic compounds in these drugs: NDMA, NDEA and NMBA, which are nitrosamines.
After announcing the widespread recall, the FDA is now trying to assure the public that they should keep taking their tainted medication.
100% organic essential oil sets now available for your home and personal care, including Rosemary, Oregano, Eucalyptus, Tea Tree, Clary Sage and more, all 100% organic and laboratory tested for safety. A multitude of uses, from stress reduction to topical first aid. See the complete listing here, and help support this news site.
The affected drugs are used to treat high blood pressure and other heart conditions. These are the kinds of medications people take every day for years. Does the FDA even know how long this contamination has been going on?
According to reports, the nitrosamine contamination is due to a change in the way Chinese companies are producing the drugs. This change took place in 2011 — which means that American consumers have potentially been taking tainted medication for the last eight years.
Federal agencies are incompetent
The reality is that the FDA can only assume that not taking your heart medication is going to be worse for your health than taking it — and its an assumption they’re probably not properly equipped to make.
Earlier this year, the FDA and other federal agencies came under fire for failing to conduct adequate safety testing on other products like pesticides. Scientists said it was impossible for government agencies to predict what effects pesticides will have in the real word — and the same can be said of any other drug or chemical.
There’s no way for the FDA to really know what effects taking these tainted drugs will have on patients until after they’ve taken them — yet the FDA is advising people take the medications anyway.
“The risk associated with abruptly discontinuing the use of these important medicines far outweighs the low risk that our scientists estimate to be associated with continuing the medicine until the patient’s doctor or pharmacist provides a safe replacement or a different treatment option,” the FDA stated.
At this point, Americans have potentially been getting tainted drugs for nearly a decade — trust in the FDA should be at rock-bottom right now, if it wasn’t already there yet. According to USA Today, the FDA knew that many of these overseas factories were in shambles, but did nothing until an independent company did their own analysis and started ruffling feathers.
In addition to cancer, research has linked nitrosamine exposure to Alzheimer’s disease, diabetes and other deleterious health conditions.
See more coverage of the latest atrocities in medicine at DangerousMedicine.com.
Sources for this article include:
The Food and Drug Administration (FDA) announced Monday that it would place a “black box” warning on a controversial contraceptive device, but stopped short of banning it.
Essure, made by German drugmaker Bayer AG, is a permanent contraceptive device consisting of metal coils that are inserted into the fallopian tubes through the vagina. Once in the fallopian tubes, scar tissue forms around the coils to block a woman’s egg from becoming fertilized.
It was touted as a safe, non-invasive form of birth control that allowed women to simply go about their lives, not having to worry about missed pills or getting an injection. But over the past several years, thousands of complaints have flooded into the Food and Drug Administration (FDA) concerning painful and sometimes irreversible complications caused by Essure.
On its website, the FDA says that reports of adverse events received by the agency include persistent pain, perforation of the uterus and/or fallopian tubes, internal abdominal bleeding, abnormal and irregular bleeding, allergy or hypersensitivity reactions, and the Essure device can migrate outside of the fallopian tubes and become lodged in other parts of the body, namely the uterus.
When the device migrates, unintended pregnancies can occur. Ectopic pregnancy is also a very real risk with Essure.
From November 2002 to May 2015, more than 5,000 women filed grievances with the FDA.
The Essure label warns of pelvic pain and bleeding immediately after implantation, but many women say their problems persisted much longer and, in some cases, required surgery to remove the device.
But recently, the FDA rejected calls from injured women to pull Essure from the market, as many women have pleaded with the agency to do. Instead, health officials say it will require Bayer AG to conduct a new round of safety studies on the device. The agency also recommended a “black box” warning – its strongest warning – about Essure’s potential for serious side effects, plus a risks checklist for doctors to discuss with patients. 
In a statement, William Maisel, chief scientist at FDA’s Center for Devices and Radiological Health, said:
“The actions we are taking today will encourage important conversations between women and their doctors to help patients make more informed decisions about whether or not Essure is right for them. They also reflect our recognition that more rigorous research is needed to better understand if certain women are at heightened risk of complications.” 
The FDA called Essure “an appropriate option for the majority of women” but that “some women may be at risk for serious complications.” 
The news of the FDA’s refusal to recall Essure was heartbreaking and frustrating news to many women who have been injured by the device, including the Facebook support group Essure Problems.
In a statement, the group said:
“We are outraged that it appears as if the FDA is going to leave Essure on the market. Take the device OFF the market and revoke PMA [premarket approval]. Do not continue to allow more women to be harmed.
“These studies could take several years, and leaving the device on the market will only put more women’s lives at risk. We are disappointed but not surprised the FDA has once again chosen to side with industry rather than protect patients of a failed medical device.”
Rep. Mike Fitzpatrick, a Republican from Pennsylvania, who had been pressuring the FDA to revoke PMA for Essure, also expressed anger and disbelief:
“It’s unbelievable that it took the FDA since September to make just two recommendations with no enforcement measures and ask the manufacturer to perform another study while leaving Essure on the market. It’s been done. The evidence is all there: Tens of thousands of injured women and hundreds of fetal deaths.”
Last week, Fitzpatrick and Madris Tomes, a former FDA contractor whose business, Device Events, analyzes FDA public data, presented the FDA with raw data showing a total of 303 fetal deaths among women who used Essure. Said Tomes:
“I actually think the 303 number is conservative, because some of these women have had multiple miscarriages, they’ve had multiple pregnancies, after confirmation, but I only counted them once.”
Fitzpatrick says Congress must act to take the dangerous contraceptive device off the market, since the FDA won’t. He said he would present a number of legislative actions to the House and Senate, including working to block government agencies, including the U.S. Department of Veterans Affairs, from purchasing the Essure; introducing new legislation that would remove “blanket civil liability protections” that block women from suing Bayer AG for their injuries; and working to pass an act that would revoke Essure’s FDA approval.
 NBC News
Author: JULIE FIDLER